KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Bristol Myers Squibb's Dividends Paid - Common rose 386.51% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 billion, marking a year-over-year increase of 407.91%. This contributed to the annual value of $4.9 billion for FY2024, which is 250.84% up from last year.
  • Bristol Myers Squibb's Dividends Paid - Common amounted to $1.3 billion in Q3 2025, which was up 386.51% from $1.3 billion recorded in Q2 2025.
  • Bristol Myers Squibb's 5-year Dividends Paid - Common high stood at $1.3 billion for Q3 2025, and its period low was $8.0 million during Q2 2021.
  • Over the past 5 years, Bristol Myers Squibb's median Dividends Paid - Common value was $1.2 billion (recorded in 2023), while the average stood at $1.1 billion.
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first crashed by 9921.65% in 2021, then surged by 987500.0% in 2023.
  • Bristol Myers Squibb's Dividends Paid - Common (Quarter) stood at $1.1 billion in 2021, then grew by 4.19% to $1.1 billion in 2022, then rose by 1.31% to $1.2 billion in 2023, then grew by 5.0% to $1.2 billion in 2024, then increased by 3.69% to $1.3 billion in 2025.
  • Its Dividends Paid - Common stands at $1.3 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.3 billion for Q1 2025.